<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="higes" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">higes</book-part-id>
      <title-group>
        <title>Autosomal Dominant Hyper IgE Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: AD-HIES, Job&#x02019;s Syndrome, STAT3-Deficient Hyper IgE Syndrome, STAT3 Deficiency</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hsu</surname>
            <given-names>Amy P</given-names>
          </name>
          <degrees>BA</degrees>
          <aff>National Institute of Allergy and Infectious Diseases<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>twins@niaid.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Davis</surname>
            <given-names>Joie</given-names>
          </name>
          <degrees>PNP-BC, APNG</degrees>
          <aff>National Institute of Allergy and Infectious Diseases<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>jdavis@niaid.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Puck</surname>
            <given-names>Jennifer M</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Professor of Pediatrics, University of California San Francisco<break/>San Francisco, California</aff>
          <email>puckj@peds.ucsf.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Holland</surname>
            <given-names>Steven M</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Chief, Laboratory of Clinical Infectious Diseases<break/>National Institute of Allergy and Infectious Diseases<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>sholland@niaid.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Freeman</surname>
            <given-names>Alexandra F</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>National Institute of Allergy and Infectious Diseases<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>freemaal@niaid.nih.gov</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>23</day>
          <month>2</month>
          <year>2010</year>
        </date>
        <date date-type="updated">
          <day>7</day>
          <month>6</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="alps" document-type="chapter">Autoimmune Lymphoproliferative Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="adnfle" document-type="chapter">Autosomal Dominant Nocturnal Frontal Lobe Epilepsy</related-object>
      <abstract id="higes.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Autosomal dominant hyper IgE syndrome (AD-HIES) is a primary immune deficiency characterized by the classic triad of recurrent skin boils, cyst-forming pneumonias, and extreme elevations of serum IgE. It is now recognized that other common manifestations include eczema, mucocutaneous candidiasis, and several connective tissue and skeletal abnormalities. A rash in the newborn period subsequently evolves into an eczematoid dermatitis. Recurrent staphylococcal skin boils and bacterial pneumonias usually manifest in the first years of life. Pneumatocoeles and bronchiectasis often result from aberrant healing of pneumonias. Mucocutaneous candidiasis is common. A characteristic facial appearance typically emerges in adolescence. Skeletal abnormalities include osteopenia, minimal trauma fractures, and scoliosis. Vascular abnormalities include middle-sized artery tortuosity and aneurysms, with infrequent clinical sequelae of myocardial infarction and subarachnoid hemorrhage. Gastrointestinal (GI) manifestations include gastroesophageal reflux disease; esophageal dysmotility; and rarely colonic perforations, some of which are associated with diverticuli. Fungal infection of the GI tract (typically histoplasmosis, <italic toggle="yes">Cryptococcus,</italic> and <italic toggle="yes">Coccidioides</italic>) also occur infrequently. Survival is typically into adulthood, but life span is often shortened. Most deaths are associated with Gram-negative (<italic toggle="yes">Pseudomonas</italic>) or filamentous fungal pneumonias resulting in hemoptysis. Lymphomas occur at an increased frequency.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis requires a high index of suspicion based on clinical features. A clinical scoring system that includes both immunologic/infectious manifestations and skeletal/connective tissue abnormalities has been developed. Molecular genetic testing of <italic toggle="yes">STAT3,</italic> the only gene in which pathogenic variants are known to cause AD-HIES, confirms the diagnosis.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> The mainstay of treatment is prevention of staphylococcal abscesses and pneumonias with anti-staphylococcal prophylactic antibiotics as well as early aggressive treatment of infections. Use of antibiotics and antifungal agents depends on the nature of the infection and the extent of involvement. Antiseptic therapies for the skin such as bleach baths are beneficial. Medications such as histamine-1 antagonists to control pruritus are helpful for more significant eczema. Optimization of calcium and vitamin D intake may be considered to improve bone health.</p>
          <p><italic toggle="yes">Surveillance:</italic> Periodic chest imaging and high clinical suspicion assist in early detection of infections. Culture of skin lesions and sputum samples helps direct therapy. Routine dental care is necessary to ensure timely removal of primary teeth to allow eruption of secondary teeth. Routine screening of adolescents for early signs of scoliosis is recommended.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>AD-HIES is inherited in an autosomal dominant manner. To date, the majority of cases have been caused by <italic toggle="yes">de novo</italic> pathogenic variants. Each child of an individual with AD-HIES has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="higes.Diagnosis">
        <title>Diagnosis</title>
        <sec id="higes.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Until the 2007 identification of <italic toggle="yes">STAT3</italic> pathogenic variants as the cause of most cases of autosomal dominant hyper-IgE syndrome (AD-HIES), diagnosis was primarily made through the long-standing classic triad of recurrent skin boils, cyst-forming pneumonias, and extreme elevations of serum concentration of immunoglobulin E (IgE).</p>
          <p>A clinical scoring system was devised by the NIH group who recognized AD-HIES to be a multisystem disorder [<xref ref-type="bibr" rid="higes.REF.grimbacher.1999b.735">Grimbacher et al 1999b</xref>]. Diagnosis now combines a high index of suspicion based on clinical features (as delineated in the clinical scoring system; see <xref ref-type="table" rid="higes.T.scoring_system_with_clinical_and">Table 1</xref>) with molecular genetic testing of <italic toggle="yes">STAT3</italic> [<xref ref-type="bibr" rid="higes.REF.holland.2007.1608">Holland et al 2007</xref>, <xref ref-type="bibr" rid="higes.REF.minegishi.2007.1058">Minegishi et al 2007</xref>]. <xref ref-type="bibr" rid="higes.REF.woellner.2010.424">Woellner et al [2010]</xref> have developed guidelines that include the NIH clinical feature scoring system as well as determination of IL-17-producing T cells.</p>
          <p>Scoring system components include both immunologic/infectious manifestations and skeletal/connective tissue abnormalities. Scores are weighted to reflect the severity of a finding and to emphasize findings that are specific for AD-HIES. In order to have a high likelihood of being affected with AD-HIES, individuals should have a combination of both immunologic/infectious features and non-immunologic features. In the NIH clinical feature scoring system, a score of:</p>
          <list list-type="bullet">
            <list-item>
              <p>&#x0003e;40 is suggestive of AD-HIES;</p>
            </list-item>
            <list-item>
              <p>20-40 is considered indeterminate;</p>
            </list-item>
            <list-item>
              <p>&#x0003c;20 is considered unlikely to indicate AD-HIES.</p>
            </list-item>
          </list>
          <table-wrap id="higes.T.scoring_system_with_clinical_and" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Scoring System with Clinical and Laboratory Tests for Individuals in Kindreds with HIES</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1">Clinical Finding</th>
                  <th id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" valign="middle" colspan="10" align="left" scope="colgroup" rowspan="1">Points&#x000a0;<sup>1</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">0</th>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">1</th>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">2</th>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">3</th>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">4</th>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">5</th>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" scope="col" rowspan="1" colspan="1">6</th>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" scope="col" rowspan="1" colspan="1">7</th>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" scope="col" rowspan="1" colspan="1">8</th>
                  <th headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2" id="hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" scope="col" rowspan="1" colspan="1">10</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Highest serum-IgE level (IU/mL)&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;200</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">200-500</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">501-1,000</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1">1,001-2,000</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;2,000</td>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Skin abscesses</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">None</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">1-2</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">3-4</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;4</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Pneumonia (episodes over lifetime)</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">None</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;3</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Parenchymal lung anomalies</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">Bronchiectasis</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1">Pneumatocoele</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Retained primary teeth</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">None</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;3</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Scoliosis, maximum curvature</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;10&#x000b0;</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">10&#x000b0;-14&#x000ba;</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">15&#x000b0;-20&#x000b0;</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;20&#x000b0;</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Fractures with minor trauma</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">None</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">1-2</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;2</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Highest eosinophil count (cells/&#x003bc;L)&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;700</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">700-800</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;800</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Characteristic face</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Mildly present</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">Present</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Midline anomaly&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">Present</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Newborn rash</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Present</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Eczema (worst stage)</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Mild</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Moderate</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Severe</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Upper-respiratory infections per year</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">1-2</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">3</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">4-6</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;6</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Candidiasis</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">None</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Oral</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Fingernails</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Systemic</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Other serious infections</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">None</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Severe</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Fatal infection</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Present</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hyperextensibility</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Present</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Lymphoma</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1">Present</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Increased nasal width&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;1 SD</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">1-2 SD</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;2 SD</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">High palate</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Present</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Young-age correction</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;5 years</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_4" valign="middle" align="left" rowspan="1" colspan="1">2-5 years</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_5" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_6" valign="middle" align="left" rowspan="1" colspan="1">1-2 years</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_7" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_8" valign="middle" align="left" rowspan="1" colspan="1">&#x02264;1 year</td>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_9" valign="middle" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_higes.T.scoring_system_with_clinical_and_1_1_1_2 hd_h_higes.T.scoring_system_with_clinical_and_1_1_2_10" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>From <xref ref-type="bibr" rid="higes.REF.grimbacher.1999b.735">Grimbacher et al [1999b]</xref></p>
              </fn>
              <fn id="higes.TF.1.1">
                <label>1. </label>
                <p>The entry in the furthest-right column is assigned the maximum points allowed for each finding.</p>
              </fn>
              <fn id="higes.TF.1.2">
                <label>2. </label>
                <p>Normal &#x0003c;130 IU/mL</p>
              </fn>
              <fn id="higes.TF.1.3">
                <label>3. </label>
                <p>700/&#x003bc;L = 1 standard deviation (SD), 800/&#x003bc;L = 2 SD above the mean value for normal individuals.</p>
              </fn>
              <fn id="higes.TF.1.4">
                <label>4. </label>
                <p>For example, cleft palate, cleft tongue, hemivertebrae, other vertebral anomaly (see <xref ref-type="bibr" rid="higes.REF.grimbacher.1999a.692">Grimbacher et al [1999a]</xref>).</p>
              </fn>
              <fn id="higes.TF.1.5">
                <label>5. </label>
                <p>Compared with age- and sex-matched controls [<xref ref-type="bibr" rid="higes.REF.farkas.1994">Farkas 1994</xref>]</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Immunologic/infectious features</bold> include elevation of serum concentration of IgE, eosinophilia, recurrent skin abscesses (often &#x0201c;cold,&#x0201d; manifesting little inflammatory reaction), pneumonias, destructive parenchymal lung lesions following infection, other serious or fatal infections, newborn rash, eczema, sinusitis or otitis and mucocutaneous candidiasis.</p>
          <p><bold>Non-immune features</bold> include three or more retained primary teeth, scoliosis, bone fractures following minimal trauma, hyperextensibility of joints, characteristic facial appearance, increased nasal width, high palate, congenital skeletal anomalies and lymphoma.</p>
          <p>Not all features need to be present to diagnose AD-HIES, and because features accrue over time, the clinical diagnosis can be uncertain in young children. Moreover, early institution of effective prophylactic antibiotics can attenuate or prevent many of the infectious complications that would otherwise facilitate diagnosis.</p>
        </sec>
        <sec id="higes.Testing">
          <title>Testing</title>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Elevated serum concentration of IgE. Serum IgE (normally &#x0003c;130 IU/mL in adults) is typically above 2000 IU/mL, but can be variable and may decrease in adulthood to normal levels.</p>
            </list-item>
            <list-item>
              <p>Eosinophilia &#x0003e;700/&#x003bc;L. Present in the majority of individuals</p>
            </list-item>
            <list-item>
              <p>Diminished memory T and B cells</p>
            </list-item>
            <list-item>
              <p>Near absence of IL-17 producing Th17 cell differentiation [<xref ref-type="bibr" rid="higes.REF.ma.2008.1551">Ma et al 2008</xref>, <xref ref-type="bibr" rid="higes.REF.milner.2008.773">Milner et al 2008</xref>, <xref ref-type="bibr" rid="higes.REF.renner.2008.181">Renner et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Chest imaging revealing pneumatocoeles or bronchiectasis, especially following recurrent pneumonias</p>
            </list-item>
            <list-item>
              <p>Spine imaging demonstrating scoliosis in approximately two thirds of individuals older than age 16 years</p>
            </list-item>
            <list-item>
              <p>Reduced bone density in approximately 50% of individuals</p>
            </list-item>
            <list-item>
              <p>Chiari 1 malformations in approximately 20% of persons, and brain MRI T<sub>2</sub>-weighted focal hyperintensities in approximately 70%</p>
            </list-item>
          </list>
          <p><bold>Protein analysis.</bold> Protein analysis is of limited diagnostic value (see <xref ref-type="sec" rid="higes.Testing_Strategy">Testing Strategy</xref>).</p>
          <sec id="higes.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">STAT3</italic> is the only gene in which pathogenic variants are known to cause autosomal dominant hyper-IgE syndrome (AD-HIES).</p>
            <p><bold>Evidence for locus heterogeneity.</bold> A small percentage (&#x0003c;5%) of individuals meeting the clinical criteria for AD-HIES do not have identifiable <italic toggle="yes">STAT3</italic> pathogenic variants, suggesting the existence of additional, as-yet unidentified loci.</p>
            <table-wrap id="higes.T.summary_of_molecular_genetic_tes" orientation="portrait" position="anchor">
              <label>Table 2. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Autosomal Dominant Hyper IgE Syndrome</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Pathogenic Variants Detected</th>
                    <th id="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Gene &#x00026; Test Method&#x000a0;<sup>2</sup></th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">STAT3</italic>
                    </td>
                    <td headers="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Missense and splice site variants and small in-frame deletions</td>
                    <td headers="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;95%&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis of select exons</td>
                    <td headers="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Variants in exons 9-23&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_higes.T.summary_of_molecular_genetic_tes_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="higes.TF.2.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="higes" object-id="higes.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="higes.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
                </fn>
                <fn id="higes.TF.2.2">
                  <label>2. </label>
                  <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
                </fn>
                <fn id="higes.TF.2.3">
                  <label>3. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="higes.TF.2.4">
                  <label>4. </label>
                  <p>More than 95% of individuals with findings typical of signal transducer and activator of transcription 3 (STAT3)-deficient hyper IgE syndrome (NIH clinical scores &#x0003e;40 with points coming from both immune and non-immune categories) have a <italic toggle="yes">STAT3</italic> pathogenic variant encoding an altered, expressed protein.</p>
                </fn>
                <fn id="higes.TF.2.5">
                  <label>5. </label>
                  <p>Exons analyzed may vary by laboratory.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="higes.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> History and physical examination using the scoring system (including both immune and non-immune categories) outlined in <xref ref-type="sec" rid="higes.Clinical_Diagnosis">Clinical Diagnosis</xref> may suggest the diagnosis.</p>
          <list list-type="bullet">
            <list-item>
              <p>Perform screening blood work to detect elevated serum concentration of IgE and eosinophilia. Other serum immunoglobulins and neutrophil/lymphocyte counts should be in the normal to near-normal range.</p>
            </list-item>
            <list-item>
              <p>For clinicians with access to research flow cytometry, greatly diminished Th17 cell number may be indicative of, but not definitive for, HIES.</p>
            </list-item>
            <list-item>
              <p>Individuals with a high clinical suspicion should have <italic toggle="yes">STAT3</italic> sequencing performed.</p>
            </list-item>
            <list-item>
              <p>If sequence analysis does not identify a pathogenic variant, cDNA analysis may be considered. An in-frame deletion that spans exons 22 and 23 has been reported; detected by cDNA analysis, the deletion would have been missed by standard genomic sequencing [<xref ref-type="bibr" rid="higes.REF.schimke.2010.611">Schimke et al 2010</xref>]. However, to date, no pathogenic variants that are out-of-frame, involve the entire gene, or otherwise result in haploinsufficiency have been reported.</p>
            </list-item>
            <list-item>
              <p>Protein analysis is of limited diagnostic value, as all pathogenic variants reported to date are protein positive and each person carries one benign allele. Phosphorylation of signal transducer and activator of transcription 3 (STAT3) has not been shown to be sensitive for the majority of pathogenic variants.</p>
            </list-item>
          </list>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="higes.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="higes.Clinical_Description">
          <title>Clinical Description</title>
          <p>Autosomal dominant hyper IgE syndrome (AD-HIES) is a primary immune deficiency syndrome characterized by elevated serum IgE, eczema, and recurrent skin and respiratory tract infections, together with several connective tissue and skeletal abnormalities.</p>
          <p><bold>Immunologic characteristics.</bold> Individuals with AD-HIES typically manifest in the newborn period with a rash, often diagnosed as eosinophilic pustulosis. The rash evolves into an eczematoid dermatitis that is often driven by staphylococcal infection [<xref ref-type="bibr" rid="higes.REF.hill.1974.183">Hill &#x00026; Quie 1974</xref>, <xref ref-type="bibr" rid="higes.REF.chamlin.2002.572">Chamlin et al 2002</xref>, <xref ref-type="bibr" rid="higes.REF.eberting.2004.1119">Eberting et al 2004</xref>].</p>
          <p>Recurrent staphylococcal boils usually manifest in the first few years of life, and may be &#x0201c;cold,&#x0201d; lacking the cardinal features of inflammation, warmth, redness, and pain.</p>
          <p>Recurrent pneumonias begin as well in the first few years, with the most common bacterial isolates being <italic toggle="yes">Staphylococcus aureus, Streptococcus pneumoniae</italic>, and <italic toggle="yes">Haemophilus influenzae</italic>. Abnormal healing of these pneumonias, pneumatocoeles, and bronchiectasis are common complications.</p>
          <p>Staphylococcal infections outside of the lung and skin, such as osteomyelitis or liver abscess, occur much less frequently.</p>
          <p>Mucocutaneous candidiasis affecting the oropharynx, vagina, fingernails, and toenails is common.</p>
          <p>Opportunistic infections may occur, including <italic toggle="yes">Pneumocystis jiroveci</italic> pneumonia, disseminated histoplasmosis and <italic toggle="yes">Cryptococcus</italic>, and secondary infection of the pneumatocoeles with molds such as <italic toggle="yes">Aspergillus fumigatus</italic> or <italic toggle="yes">Scedosporium</italic> species.</p>
          <p>Decreased central memory T-cell formation may lead to increased incidence of varicella zoster virus (VZV) reactivation and modestly increased levels of circulating Epstein-Barr virus (EBV) [<xref ref-type="bibr" rid="higes.REF.siegel.2011.806">Siegel et al 2011</xref>].</p>
          <p><bold>Non-immunologic characteristics.</bold> Individuals with AD-HIES have several connective tissue, skeletal, and vascular abnormalities.</p>
          <p>A characteristic facial appearance typically emerges by adolescence characterized by facial asymmetry, deep-set eyes, a broad nose, and prominent skin pores [<xref ref-type="bibr" rid="higes.REF.borges.1998.303">Borges et al 1998</xref>; <xref ref-type="bibr" rid="higes.REF.grimbacher.1999a.692">Grimbacher et al 1999a</xref>]. A high arched palate is common, as are oral mucosal variants including palatal ridges [<xref ref-type="bibr" rid="higes.REF.domingo.2008.73">Domingo et al 2008</xref>]. Failure of primary teeth exfoliation is common; secondary tooth development is normal if the primary teeth are removed.</p>
          <p>Skeletal abnormalities include osteopenia, minimal trauma fractures, and scoliosis. Scoliosis typically develops through childhood and adolescence, and may require surgical correction. Joint hyperextensibilty is common, and adults may have degenerative joint disease. Varying degrees of craniosynostosis can be seen, although surgical correction is rarely required. Skull radiographs often have a beaten copper appearance.</p>
          <p>Brain imaging reveals Chiari 1 malformations in approximately 20% of individuals and focal hyperintensities prominent on T<sub>2</sub>-weighted images in approximately 70% of individuals. The focal hyperintensities are usually localized to the white matter and tend to increase in number with age. Both the Chiari 1 malformations and the hyperintensities are usually asymptomatic [<xref ref-type="bibr" rid="higes.REF.freeman.2007a.e1121">Freeman et al 2007a</xref>].</p>
          <p>Vascular abnormalities including middle-sized arterial tortuosity and aneurysms have been described [<xref ref-type="bibr" rid="higes.REF.ling.2007.255">Ling et al 2007</xref>, <xref ref-type="bibr" rid="higes.REF.freeman.2011.338">Freeman et al 2011</xref>, <xref ref-type="bibr" rid="higes.REF.chandesris.2012.25">Chandesris et al 2012</xref>]. The coronary arteries have been the most completely studied. The combination of tortuosity and dilation is found in approximately 50% of affected individuals; either abnormality is present in approximately 70%. Clinical sequelae have been rare but include myocardial infarction. Cerebral artery aneurysm has also been described and infrequently associated with subarachnoid hemorrhage.</p>
          <p>Symptoms of esophageal dysmotility are present in more than 50% of individuals and manifest as gastrointestinal reflux disease and dysphagia. Upper endoscopy frequently shows eosinophilic esophagitis. Diverticuli can occur at a relatively young age and may be associated with bowel perforation [<xref ref-type="bibr" rid="higes.REF.stover.2010.1261">Stover et al 2010</xref>]. Isolated colonic perforations have also been described.</p>
          <p><bold>Major causes of morbidity and mortality.</bold> Survival is typically into adulthood, but a shortened life span is typical. Most deaths of individuals with AD-HIES are associated with Gram-negative (<italic toggle="yes">Pseudomonas</italic>) or filamentous fungal pneumonias (most commonly <italic toggle="yes">Aspergillus</italic>) infecting damaged lung parenchyma (i.e., pneumatocoeles, bronchiectasis) [<xref ref-type="bibr" rid="higes.REF.freeman.2007b.1234">Freeman et al 2007b</xref>]. Fungi may invade the pulmonary vasculature leading to massive hemoptysis, or may disseminate to multiple organs.</p>
          <p>Complications of arterial aneurysms have included myocardial infarction related to coronary artery aneurysm and subarachnoid hemorrhage related to intracranial aneurysm [<xref ref-type="bibr" rid="higes.REF.fathi.2011.704">Fathi et al 2011</xref>].</p>
          <p>Lymphomas occur at an increased frequency and treatment has been successful with standard chemotherapy. Other malignancies have been reported [<xref ref-type="bibr" rid="higes.REF.leonard.2004.2521">Leonard et al 2004</xref>].</p>
        </sec>
        <sec id="higes.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No heritable differences in phenotype have been identified in individuals with STAT3-deficient hyper IgE syndrome [<xref ref-type="bibr" rid="higes.REF.heimall.2011.75">Heimall et al 2011</xref>]. Pathogenic variants tend to cluster in the DNA-binding and SH2 domains with few affected individuals having pathogenic variants in the transactivation domain and only one to date in the N-terminal domain [<xref ref-type="bibr" rid="higes.REF.holland.2007.1608">Holland et al 2007</xref>; <xref ref-type="bibr" rid="higes.REF.minegishi.2007.1058">Minegishi et al 2007</xref>; <xref ref-type="bibr" rid="higes.REF.renner.2008.181">Renner et al 2008</xref>; Holland et al, unpublished].</p>
        </sec>
        <sec id="higes.Penetrance">
          <title>Penetrance</title>
          <p>Intrafamilial variability is minimal and penetrance appears to be complete.</p>
        </sec>
        <sec id="higes.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation has not been observed in STAT3<italic toggle="yes">-</italic>deficient hyper IgE syndrome.</p>
          <p>Although some reports suggest increasing severity of AD-HIES in successive generations, it is likely that these were instances of milder disease associated with mosaicism for a <italic toggle="yes">STAT3</italic> pathogenic variant in the first generation and more severe disease associated with a <italic toggle="yes">STAT3</italic> constitutional pathogenic variant in the second and subsequent generations.</p>
        </sec>
        <sec id="higes.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of STAT3-deficient hyper IgE syndrome is unknown. The condition is rare. Enrichment in a specific ethnic or racial group has not been reported; gender preference is not seen.</p>
        </sec>
      </sec>
      <sec id="higes.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are known to be associated with pathogenic variants in <italic toggle="yes">STAT3</italic>.</p>
      </sec>
      <sec id="higes.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Atopic dermatitis.</bold> Individuals with severe atopic dermatitis are often suspected of having HIES because of the shared elevation of serum concentration of IgE, and many individuals with atopic dermatitis have recurrent staphylococcal skin infections. However, the other features of AD-HIES are typically not present, and individuals with severe atopic dermatitis often have increased numbers and severity of allergies (e.g., environmental, food that may lead to anaphylaxis) than do individuals with AD-HIES.</p>
        <p><bold>Autosomal recessive hyper IgE syndrome (AR-HIES)</bold> is a distinct clinical disorder, characterized by elevated serum concentration of IgE, severe eczema, and recurrent skin and lung infections [<xref ref-type="bibr" rid="higes.REF.renner.2004.93">Renner et al 2004</xref>]. It differs from STAT3-deficient hyper IgE syndrome by an increased incidence of neurologic abnormalities, an increased occurrence of viral infections of the skin (e.g., <italic toggle="yes">Molluscum contagiosum</italic>, warts), and absence of the non-immunologic findings of AD-HIES (e.g., retention of primary teeth) [<xref ref-type="bibr" rid="higes.REF.renner.2004.93">Renner et al 2004</xref>]. Pathogenic variants in <italic toggle="yes">DOCK8</italic> have now been identified as a cause of AR-HIES.</p>
        <p>Combined immunodeficiency associated with <italic toggle="yes">DOCK8</italic> pathogenic variants is characterized by eczema, allergies, sinopulmonary infections, and viral skin infections including herpes simplex virus (HSV), varicella-zoster virus (VZV), <italic toggle="yes">Molluscum contagiosum</italic>, and human papillomavirus (HPV) [<xref ref-type="bibr" rid="higes.REF.zhang.2009.2046">Zhang et al 2009</xref>, <xref ref-type="bibr" rid="higes.REF.engelhardt.2009.1289">Engelhardt et al 2009</xref>]. Affected individuals have increased risk for malignancy; squamous cell carcinomas and lymphoma have been reported. DOCK8 deficiency is frequently associated with lymphopenia, which often progresses with age, and serum IgM levels may be low or undetectable. Eosinophilia and IgE are both variable, but can be extremely elevated.</p>
        <p><bold>TYK2 deficiency.</bold> A single report of human TYK2 deficiency described moderately high serum concentration of IgE in conjunction with disseminated bacillus Calmette-Gu&#x000e9;rin (BCG) infection and susceptibility to viral and other infections [<xref ref-type="bibr" rid="higes.REF.minegishi.2006.745">Minegishi et al 2006</xref>]. However, subsequent reports of TYK2 deficiency have not been associated with the AR-HIES phenotype [<xref ref-type="bibr" rid="higes.REF.kilic.2012.1055">Kilic et al 2012</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="was" document-type="chapter"><bold>Wiskott-Aldrich syndrome</bold></related-object>
<bold>(WAS)</bold> is an X-linked recessive disorder caused by pathogenic variants in <italic toggle="yes">WAS</italic>. Similar to HIES, eczema and recurrent infections are present, but WAS has associated thrombocytopenia, a high incidence of autoimmune disease and lymphoma in later childhood and adulthood, and typically more opportunistic infections than seen in HIES. Wiskott-Aldrich syndrome occurs in males, although there have been isolated cases of affected females with skewed X-inactivation resulting in the disease phenotype [<xref ref-type="bibr" rid="higes.REF.parolini.1998.291">Parolini et al 1998</xref>]. Thrombocytopenia with small platelets is a distinguishing feature.</p>
        <p><bold>Netherton syndrome</bold> is an autosomal recessive disorder caused by pathogenic variants in <italic toggle="yes">SPINK5</italic>. Netherton syndrome is associated with elevated IgE and rash; however, the rash is typically more ichthyotic in appearance with associated trichorrhexis invaginata (bamboo hair). Frequently an enteropathy is present with failure to thrive.</p>
        <p><bold>Omenn syndrome</bold> also presents in the newborn period with rash and typically elevated serum IgE. Omenn syndrome is a form of <related-object link-type="booklink" source-id="gene" document-id="x-scid" document-type="chapter">SCID</related-object> (severe combined immunodeficiency) that can result from pathogenic variants in <italic toggle="yes">RAG1</italic> or <italic toggle="yes">RAG2</italic>, <italic toggle="yes">DCLRE1C</italic> (previously known as Artemis)<italic toggle="yes">, IL2RG,</italic> and additional combined immunodeficiency genes that allow residual functional activity. Affected infants are usually sicker than those with HIES and have associated lymphadenopathy, hepatosplenomegaly, and opportunistic infections.</p>
      </sec>
      <sec id="higes.Management">
        <title>Management</title>
        <sec id="higes.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with hyper IgE syndrome (HIES), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Dermatologic examination</p>
            </list-item>
            <list-item>
              <p>Chest imaging</p>
            </list-item>
            <list-item>
              <p>Evaluation for scoliosis</p>
            </list-item>
            <list-item>
              <p>Dental examination for possible retention of primary teeth</p>
            </list-item>
          </list>
        </sec>
        <sec id="higes.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Currently, there is no cure or targeted treatment for AD-HIES, and the mainstay of therapy is prevention of staphylococcal abscesses and pneumonias with anti-staphylococcal prophylactic antibiotics as well as early aggressive treatment of infections. It is important to institute antibiotic therapy at the earliest sign of infection. Many affected individuals progress from minor to major infection rapidly, and systemic signs of infection may be minimal.</p>
          <list list-type="bullet">
            <list-item>
              <p>Prophylactic antibiotics targeting <italic toggle="yes">Staphylococcus aureus</italic> and other pyogenic bacteria are primarily used to prevent the pneumonias and their complications.</p>
            </list-item>
            <list-item>
              <p>If structural damage to the lungs (e.g., bronchiectasis and/or pneumatocoeles) occurs, the breadth of antimicrobial coverage is usually extended, as these structural abnormalities become secondarily infected with Gram-negative bacteria (e.g., <italic toggle="yes">Pseudomonas</italic>) or fungi (e.g., <italic toggle="yes">Aspergillus</italic>).</p>
            </list-item>
            <list-item>
              <p>The combination of prophylactic antimicrobials and aggressive diagnosis and treatment of pneumonias helps to diminish these secondary lung parenchymal abnormalities.</p>
            </list-item>
            <list-item>
              <p>Continued use of antifungal agents to control mucocutaneous candidiasis and to prevent pulmonary disease may be necessary.</p>
            </list-item>
          </list>
          <p>The skin disease of eczema and recurrent boils is usually well controlled with antiseptic therapies such as diluted bleach baths (~1/2 - 1 cup of bleach per bath tub of water for 15 minutes 3 times weekly) or frequent swimming in a chlorinated pool.</p>
          <list list-type="bullet">
            <list-item>
              <p>Adequate skin lubrication is needed with frequent bleach baths.</p>
            </list-item>
            <list-item>
              <p>Medications such as histamine-1 antagonists to control pruritus are helpful for more significant eczema.</p>
            </list-item>
          </list>
          <p>Intravenous or subcutaneous immunoglobulin is used with anecdotal improvement for some individuals, especially those who fail to make protective levels of specific antibodies following vaccination challenge; but prospective, randomized controlled studies of immunoglobulin supplementation have not been performed.</p>
          <p>There is no known treatment or prevention for the non-immunologic characteristics.</p>
          <list list-type="bullet">
            <list-item>
              <p>As many individuals have osteopenia and minimal trauma fractures, optimizing of calcium and vitamin D intake is prudent. The role of medications such as bisphosphonates for persons with AD-HIES with osteoporosis is largely unexplored.</p>
            </list-item>
            <list-item>
              <p>Optimal blood pressure management seems appropriate in light of the arterial abnormalities.</p>
            </list-item>
            <list-item>
              <p>Anti-platelet or anticoagulation therapies may be considered for individuals with significant coronary artery aneurysms to prevent myocardial infarction related to clotting with aneurysm.</p>
            </list-item>
            <list-item>
              <p>However, any anti-clotting therapies need to be weighed against the risk of hemoptysis, a recognized complication of fungal or bacterial lung disease in individuals with AD-HIES.</p>
            </list-item>
          </list>
          <p>The role of hematopoietic cell transplantation (HSCT) in AD-HIES remains unknown. An adult treated for lymphoma with HSCT had improvement of many of the clinical features of HIES and decreasing IgE concentrations, but then died of transplant-related complications [<xref ref-type="bibr" rid="higes.REF.nester.1998.162">Nester et al 1998</xref>]. A young girl with recurrent infections had full engraftment and reduction of serum IgE concentration that rebounded with the cessation of immunosuppression [<xref ref-type="bibr" rid="higes.REF.gennery.2000.1303">Gennery et al 2000</xref>]. Recently, two unrelated affected teenagers who received HSCT for non-Hodgkin lymphoma were reported. Their immunologic and non-immunologic features, such as osteoporosis and course facial skin, were corrected [<xref ref-type="bibr" rid="higes.REF.goussetis.2010.392">Goussetis et al 2010</xref>].</p>
        </sec>
        <sec id="higes.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>Prophylactic antimicrobials are used to decrease the number of boils and pneumonias. Aberrant healing from pyogenic pneumonias leads to bronchiectasis and pneumatocoeles; therefore, prevention of these pneumonias may lead to better preservation of lung parenchyma and decreased risk of secondary, more difficult to treat pulmonary infections. The role of prophylactic antifungals to prevent pulmonary mold infections is unknown.</p>
          <p>Osteoporosis and minimal trauma fractures are frequent findings. The effect of calcium and vitamin D supplementation is not known.</p>
        </sec>
        <sec id="higes.Surveillance">
          <title>Surveillance</title>
          <p>Individuals with AD-HIES often lack systemic signs of infection and feel better than one would expect when actively infected; therefore, a high index of suspicion for infection is necessary to permit recognition of pneumonias and institution of antibiotic treatment prior to development of extensive lung damage.</p>
          <list list-type="bullet">
            <list-item>
              <p>Periodic chest imaging is helpful, especially if pneumonias have occurred, to assess whether structural lesions to the lung (e.g., pneumatocoeles) have formed.</p>
            </list-item>
            <list-item>
              <p>Because the microbiology of damaged lung tissue may change over time, it is important to obtain sputum samples intermittently and with acute infections, to direct therapy. Sputum samples should be obtained for microbiology during lung infections.</p>
            </list-item>
          </list>
          <p>Scoliosis screening of adolescents is indicated to guide any necessary intervention.</p>
          <p>Dental visits should ensure that primary teeth are removed in a timely fashion if necessary to allow secondary teeth to emerge.</p>
          <p>Periodic laboratory monitoring should be performed for individuals on chronic antimicrobial therapy.</p>
          <p>Individuals with AD-HIES have an increased incidence of lymphoma, which should be considered in the evaluation of lymphadenopathy, masses, or bony lesions.</p>
        </sec>
        <sec id="higes.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Molecular genetic testing of at-risk relatives of a proband with a known pathogenic variant allows for early diagnosis.</p>
          <p>See <xref ref-type="sec" rid="higes.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="higes.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Cessation of prophylactic antimicrobials is often advised during pregnancy. This may increase the risk of infection and should be taken into consideration. There have been pregnancies without complication, but also instances in which lung disease has worsened after pregnancy, potentially from limited antimicrobial options, delayed radiographic diagnosis, and impaired pulmonary clearance.</p>
          <p>Risks associated with pregnancy should be discussed with affected females who have pulmonary compromise, severe scoliosis, or other complications of AD-HIES.</p>
        </sec>
        <sec id="higes.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="higes.Other">
          <title>Other</title>
          <p>Parents have reported anecdotally that due to the severe eczema of their child, there have been occasions when the health care providers have alerted Child Protective Services reporting that the child is not being kept clean. While skin hygiene is very important, in spite of the best efforts of caregivers, sometimes the skin flares are severe. Questions about parental neglect/abuse have also arisen when a toddler or young child appears with evidence of repeated fractures. Health care providers who are attuned to these possibilities can serve as important advocates for the parents and family.</p>
        </sec>
      </sec>
      <sec id="higes.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="higes.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Autosomal dominant hyper IgE syndrome associated with mutation of <italic toggle="yes">STAT3</italic> is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="higes.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with autosomal dominant hyper IgE syndrome have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with autosomal dominant hyper IgE syndrome often has the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The majority of cases reported to date have been caused by <italic toggle="yes">de novo</italic> pathogenic variants. Simplex cases (i.e., a single occurrence in a family) are common.</p>
            </list-item>
            <list-item>
              <p>Individuals with some findings of hyper IgE syndrome have had mosaicism for a <italic toggle="yes">STAT3</italic> pathogenic variant and have transmitted the variant to offspring [<xref ref-type="bibr" rid="higes.REF.holland.2007.1608">Holland et al 2007</xref>; Hsu and Holland, unpublished data]</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include clinical evaluation and/or molecular genetic testing. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of a milder phenotypic presentation. Mosaicism may also lead to a milder phenotype. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband is low, but not entirely absent. The risk to the sibs of a proband with unaffected parents is higher than that of the general population because of the possibility of germline mosaicism in a parent.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with autosomal dominant hyper IgE syndrome has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected, his or her family members may be at risk.</p>
        </sec>
        <sec id="higes.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="higes.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant</bold>. When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="higes.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">STAT3</italic> pathogenic variant has been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for AD-HIES are possible.</p>
        </sec>
      </sec>
      <sec id="higes.Resources">
        <title>Resources</title>
      </sec>
      <sec id="higes.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">STAT3</italic> has 24 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="higes" object-id="higes.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign variants.</bold> There are normal splice variants (see <related-object source-id="gene" document-id="higes" object-id="higes.molgen.TA">Table A</related-object>, <bold>Gene</bold>); there are also rare allelic variants in healthy populations.</p>
        <p><bold>Pathogenic variants.</bold> Pathogenic variants identified to date include missense variants, single amino-acid in-frame deletions, and splice variants of exon 12 resulting in a ten amino-acid in-frame deletion at the start of the DNA binding domain [<xref ref-type="bibr" rid="higes.REF.renner.2008.181">Renner et al 2008</xref>; Hsu, unpublished]. There are several hotspot variants in the SH2 and DNA binding domain. Four recurrent variants occur at CpG dinucleotides: c.1144C&#x0003e;T, c.1145G&#x0003e;A, c.1268G&#x0003e;A, and c.1909G&#x0003e;A (see <xref ref-type="table" rid="higes.T.selected_stat3_pathogenic_varian">Table 3</xref>) as well as a recurrent three-base in-frame deletion, c.1387_1389delGTG. The first three account for 64 of 97 identified variants within the DNA binding domain (66%) while the last represents 27 of 55 variants in the SH2 domain (49%). When the recurrent deletion is included, these five changes account for 61% of pathogenic variants identified in <italic toggle="yes">STAT3</italic>. Two unrelated individuals were identified with a 3.9-kb deletion spanning exons 22 and 23 resulting in an in-frame deletion of 53 amino acids [<xref ref-type="bibr" rid="higes.REF.schimke.2010.611">Schimke et al 2010</xref>].</p>
        <table-wrap id="higes.T.selected_stat3_pathogenic_varian" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">STAT3</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1144C&#x0003e;T&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg382Trp</td>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_3" rowspan="5" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nucleotide/47080104">NM_139276.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/21618340">NP_644805.1</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1145G&#x0003e;A&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg382Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1268G&#x0003e;A&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg423Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1387_1389delGTG</td>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val463del</td>
              </tr>
              <tr>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1909G&#x0003e;A&#x000a0;<sup>1</sup></td>
                <td headers="hd_h_higes.T.selected_stat3_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val637Met</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="higes.TF.3.1">
              <label>1. </label>
              <p>Recurrent variants; see <bold>Pathogenic variants</bold>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> Signal transducer and activator of transcription 3 (STAT3) is a major signal transduction protein involved in many diverse pathways such as wound healing, immunity, cancer, and vascular remodeling.</p>
        <p><bold>Abnormal gene product.</bold> Expression of a mutated gene product is the rule; thus pathogenic missense variants, in-frame splice variants, and in-frame insertions/deletions have been associated with AD-HIES. Null alleles have not been detected, consistent with the hypothesis that dominant interfering pathogenic variants are required to produce the condition. Homozygous <italic toggle="yes">Stat3</italic> knockout mice are embryonic lethal while the heterozygous mice are reported to be phenotypically normal [<xref ref-type="bibr" rid="higes.REF.takeda.1997.3801">Takeda et al 1997</xref>], supporting the dominant-negative mechanism of disease.</p>
      </sec>
      <sec id="higes.References">
        <title>References</title>
        <sec id="higes.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="higes.Literature_Cited.reflist0">
            <ref id="higes.REF.borges.1998.303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Borges</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hensley</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carey</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrak</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>HR</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>The face of Job.</article-title>
                <source>J Pediatr</source>
                <volume>133</volume>
                <fpage>303</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9709729</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.chamlin.2002.572">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chamlin</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCalmont</surname>
                    <given-names>TH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>BB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esterly</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>CH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallory</surname>
                    <given-names>SB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamburro</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frieden</surname>
                    <given-names>IJ</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cutaneous manifestations of hyper-IgE syndrome in infants and children.</article-title>
                <source>J Pediatr</source>
                <volume>141</volume>
                <fpage>572</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12378200</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.chandesris.2012.25">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chandesris</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azarine</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ong</surname>
                    <given-names>KT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taleb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boutouyrie</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mousseaux</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Romain</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bozec</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boddaert</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thumerelle</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tillie-Leblond</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoarau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebranchu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aladjidi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tron</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlogis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Body</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munzer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaussaud</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suarez</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cl&#x000e9;ment</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermine</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tedgui</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lortholary</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mallat</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency.</article-title>
                <source>Circ Cardiovasc Genet.</source>
                <year>2012</year>
                <volume>5</volume>
                <fpage>25</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">22084479</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.domingo.2008.73">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Domingo</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tianxia</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>TC</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Novel intraoral phenotypes in hyperimmunoglobulin-E syndrome.</article-title>
                <source>Oral Dis.</source>
                <volume>14</volume>
                <fpage>73</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">18173452</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.eberting.2004.1119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eberting</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Dermatitis and the newborn rash of hyper-IgE syndrome.</article-title>
                <source>Arch Dermatol</source>
                <volume>140</volume>
                <fpage>1119</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">15381553</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.engelhardt.2009.1289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Engelhardt</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGhee</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winkler</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sassi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woellner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-Herrera</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lloret</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ehl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfeifer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veelken</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niehues</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siepermann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weinspach</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reisli</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keles</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutukculer</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camcio&#x0011f;lu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karakoc-Aydiner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barlan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Degerliyurt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrogrande</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeganeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baz</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Tamemi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCabe</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chatila</surname>
                    <given-names>TA</given-names>
                  </name>
                </person-group>
                <article-title>Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <year>2009</year>
                <volume>124</volume>
                <fpage>1289</fpage>
                <lpage>302.e4</lpage>
                <pub-id pub-id-type="pmid">20004785</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.farkas.1994">
              <mixed-citation publication-type="book">Farkas L. <italic toggle="yes">Anthropometry of the Head and Face.</italic> 2 ed. New York, NY: Raven Press; 1994:286-301</mixed-citation>
            </ref>
            <ref id="higes.REF.fathi.2011.704">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fathi</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vortmeyer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pluta</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Intracranial aneurysms associated with hyperimmunoglobulinaemia E (Job) syndrome: report of two cases.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>82</volume>
                <fpage>704</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">20861064</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.freeman.2011.338">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avila</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matta</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hadigan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pettigrew</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gharib</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Coronary artery abnormalities in Hyper-IgE syndrome.</article-title>
                <source>J Clin Immunol</source>
                <volume>31</volume>
                <fpage>338</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">21494893</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.freeman.2007a.e1121">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collura-Burke</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patronas</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ilcus</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darnell</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2007a</year>
                <article-title>Brain abnormalities in patients with hyperimmunoglobulin E syndrome.</article-title>
                <source>Pediatrics</source>
                <volume>119</volume>
                <fpage>e1121</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17438082</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.freeman.2007b.1234">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kleiner</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadiminti</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quezado</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2007b</year>
                <article-title>Causes of death in hyper-IgE syndrome.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <volume>119</volume>
                <fpage>1234</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">17335882</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.gennery.2000.1303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flood</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Bone marrow transplantation does not correct the hyper IgE syndrome.</article-title>
                <source>Bone Marrow Transplant</source>
                <volume>25</volume>
                <fpage>1303</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10871737</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.goussetis.2010.392">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Goussetis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peristeri</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitra</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traeger-Synodinos</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Theodosaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Psarra</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanariou</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzortzatou-Stathopoulou</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrakou</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fylaktou</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanavakis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graphakos</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <volume>126</volume>
                <fpage>392</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20584545</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.grimbacher.1999a.692">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Connell</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>1999a</year>
                <article-title>Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.</article-title>
                <source>N Engl J Med.</source>
                <volume>340</volume>
                <fpage>692</fpage>
                <lpage>702</lpage>
                <pub-id pub-id-type="pmid">10053178</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.grimbacher.1999b.735">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;ffer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buckley</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espa&#x000f1;ol</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garty</surname>
                    <given-names>BZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matamoros</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochs</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renner</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wellinghausen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>1999b</year>
                <article-title>Genetic linkage of hyper-IgE syndrome to chromosome 4.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>735</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">10441580</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.heimall.2011.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heimall</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gu</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES)</article-title>
                <source>Clin Immunol.</source>
                <volume>139</volume>
                <fpage>75</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">21288777</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.hill.1974.183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quie</surname>
                    <given-names>PG</given-names>
                  </name>
                </person-group>
                <year>1974</year>
                <article-title>Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections.</article-title>
                <source>Lancet</source>
                <volume>1</volume>
                <fpage>183</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">4129875</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.holland.2007.1608">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeLeo</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elloumi</surname>
                    <given-names>HZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brodsky</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demidowich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darnell</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Welch</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuhns</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frucht</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malech</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallin</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobayashi</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitney</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voyich</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musser</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woellner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;ffer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>STAT3 mutations in the hyper-IgE syndrome.</article-title>
                <source>N Engl J Med.</source>
                <volume>357</volume>
                <fpage>1608</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">17881745</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.kilic.2012.1055">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kilic</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hacimustafaoglu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boisson-Dupuis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kreins</surname>
                    <given-names>AY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abel</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casanova</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A Patient with Tyrosine Kinase 2 Deficiency without Hyper-IgE Syndrome.</article-title>
                <source>J Pediatr.</source>
                <volume>160</volume>
                <fpage>1055</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22402565</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.leonard.2004.2521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posadas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrmann</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>VL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaffe</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Non-Hodgkin's lymphoma in Job's syndrome: a case report and literature review.</article-title>
                <source>Leuk Lymphoma.</source>
                <volume>45</volume>
                <fpage>2521</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15621772</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.ling.2007.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ling</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gharib</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lederman</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosing</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome.</article-title>
                <source>Clin Immunol.</source>
                <volume>122</volume>
                <fpage>255</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17098478</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.ma.2008.1551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chew</surname>
                    <given-names>GY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simpson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Priyadarshi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fulcher</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tangye</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3.</article-title>
                <source>J Exp Med.</source>
                <volume>205</volume>
                <fpage>1551</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18591410</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.milner.2008.773">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milner</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenchley</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurence</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elias</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kanno</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spalding</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elloumi</surname>
                    <given-names>HZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paulson</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asher</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Shea</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paul</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douek</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.</article-title>
                <source>Nature.</source>
                <volume>452</volume>
                <fpage>773</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">18337720</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.minegishi.2006.745">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Minegishi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morio</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agematsu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuchiya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawamura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaneko</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuge</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yachie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakiyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwata</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bessho</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohishi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joh</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imai</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kogawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinohara</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujieda</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakiguchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochs</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renner</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansson</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mizutani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyawaki</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonoyama</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karasuyama</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.</article-title>
                <source>Immunity.</source>
                <volume>25</volume>
                <fpage>745</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">17088085</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.minegishi.2007.1058">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Minegishi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuchiya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuge</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawamura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ariga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stojkovic</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karasuyama</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.</article-title>
                <source>Nature.</source>
                <volume>448</volume>
                <fpage>1058</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">17676033</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.nester.1998.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nester</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagnon</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reilly</surname>
                    <given-names>WF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spitzer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjeldsberg</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>HR</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Effects of allogeneic peripheral stem cell transplantation in a patient with job syndrome of hyperimmunoglobulinemia E and recurrent infections.</article-title>
                <source>Am J Med.</source>
                <volume>105</volume>
                <fpage>162</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9727824</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.parolini.1998.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parolini</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ressmann</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haas</surname>
                    <given-names>OA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pawlowsky</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gadner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knapp</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holter</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>X-linked Wiskott-Aldrich Syndrome in a Girl.</article-title>
                <source>N Engl J Med.</source>
                <volume>338</volume>
                <fpage>291</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9445409</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.renner.2004.93">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renner</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frosch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity.</article-title>
                <source>J Pediatr</source>
                <volume>144</volume>
                <fpage>93</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">14722525</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.renner.2008.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Renner</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rylaarsdam</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anover-Sombke</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rack</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichenbach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carey</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansson</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barboza</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimke</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Getz</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torgerson</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochs</surname>
                    <given-names>HD</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <volume>122</volume>
                <fpage>181</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18602572</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.schimke.2010.611">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schimke</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawalle-Belohradsky</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roesler</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wollenberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rack</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rieber</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maass</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dopfer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichenbach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wahn</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoenig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jansson</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roesen-Wolff</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaub</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochs</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torgerson</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belohradsky</surname>
                    <given-names>BH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renner</surname>
                    <given-names>ED</given-names>
                  </name>
                </person-group>
                <article-title>Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <year>2010</year>
                <volume>126</volume>
                <fpage>611</fpage>
                <lpage>7.e1</lpage>
                <pub-id pub-id-type="pmid">20816194</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.siegel.2011.806">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heimall</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brittain</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brenchley</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Douek</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahle</surname>
                    <given-names>GH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milner</surname>
                    <given-names>JD</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory.</article-title>
                <source>Immunity.</source>
                <volume>35</volume>
                <fpage>806</fpage>
                <lpage>18</lpage>
                <pub-id pub-id-type="pmid">22118528</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.stover.2010.1261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stover</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>PW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hummell</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ness</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Diverticulitis in a young man with hyper-IgE syndrome.</article-title>
                <source>South Med J.</source>
                <volume>103</volume>
                <fpage>1261</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">21037522</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.takeda.1997.3801">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takeda</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noguchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanaka</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshida</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kishimoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akira</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>94</volume>
                <fpage>3801</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9108058</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.woellner.2010.424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Woellner</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gertz</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000e4;ffer</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lagos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perro</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glocker</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrogrande</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossu</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franco</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matamoros</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrucha</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heropolita&#x00144;ska-Pliszka</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeganeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espa&#x000f1;ol</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ehl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gennery</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breborowicz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niehues</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilic</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Junker</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turvey</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plebani</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;nchez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garty</surname>
                    <given-names>BZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pignata</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cancrini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Litzman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanal</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacchetta</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hsu</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>JN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hammarstr&#x000f6;m</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eren</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arkwright</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moilanen</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viemann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mar&#x000f3;di</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puck</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimbacher</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.</article-title>
                <source>J Allergy Clin Immunol.</source>
                <volume>125</volume>
                <fpage>424</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">20159255</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.zhang.2009.2046">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamborn</surname>
                    <given-names>IT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jing</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favreau</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>HF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turner</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uzel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Su</surname>
                    <given-names>HC</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Combined immunodeficiency associated with DOCK8 mutations.</article-title>
                <source>N Engl J Med.</source>
                <volume>361</volume>
                <fpage>2046</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">19776401</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="higes.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="higes.Suggested_Reading.reflist0">
            <ref id="higes.REF.freeman.2008.277">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Freeman</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holland</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The hyper-IgE syndromes.</article-title>
                <source>Immunol Allergy Clin North Am.</source>
                <volume>28</volume>
                <fpage>277</fpage>
                <lpage>91</lpage>
                <comment>viii</comment>
                <pub-id pub-id-type="pmid">18424333</pub-id>
              </element-citation>
            </ref>
            <ref id="higes.REF.grimbacher.2007">
              <mixed-citation publication-type="book">Grimbacher B, Puck JM, Holland SM. Hyper-IgE syndrome. In: Ochs H, Smith HIE, Puck JM, eds. <italic toggle="yes">Primary Immunodeficiency Diseases: a Molecular and Genetic Approach.</italic> 2 ed. New York, NY: Oxford University Press; 2007:496-504.</mixed-citation>
            </ref>
            <ref id="higes.REF.olaiwan.2011.1167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Olaiwan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandesris</surname>
                    <given-names>MO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraitag</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lortholary</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermine</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Prost</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodemer</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Cutaneous findings in sporadic and familial autosomal dominant hyper-IgE syndrome: a retrospective, single-center study of 21 patients diagnosed using molecular analysis.</article-title>
                <source>J Am Acad Dermatol.</source>
                <volume>65</volume>
                <fpage>1167</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">21703716</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="higes.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="higes.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 June 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>23 February 2010 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>16 July 2009 (jp) Original submission</p>
            </list-item>
          </list>
          <p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <italic toggle="yes">GeneReview</italic> &#x02018;Autosomal Dominant Hyper IgE Syndrome&#x02019; is in the public domain in the United States of America</p>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
